InvestorsHub Logo

twointen

05/19/17 7:57 AM

#6331 RE: Doctor_Hari_Seldon #6320

I completely agree with you. For most stem cell stocks it has been a long and difficult ride over the last 10 years. It seems that after much trial and a long learning curve, there is a lot of advancement more recently. I believe many of these companies are self financed and getting stocks and options as additional compensation. This happens when management and employees believe in the mission.
Almost all if these stocks seem like junk....until they have a breakthrough.